Graphene Oxide Nanosheet Noncovalent Drug Complexes for Dual-Drug Delivery in Glioblastoma Models

- 343425
Poster Presentation
Favorite this paper
How to cite this paper?
Abstract

Glioblastoma (GBM) remains one of the most aggressive brain tumors, with limited therapeutic options and poor patient prognosis. Graphene oxide (GO)-based drug delivery systems have emerged as a promising strategy to overcome these challenges. Owing to its high surface area, amphiphilic nature, and versatile surface chemistry, GO enables efficient drug loading while maintaining favorable biocompatibility and physicochemical properties. Building on these advantages, GO-based supramolecular complexes were engineered to co-deliver temozolomide (TMZ), the standard-of-care chemotherapeutic agent for GBM, and AZD1390 (AZD), a novel brain-penetrant inhibitor of Ataxia-Telangiectasia Mutated (ATM) kinase, within a single nanocarrier. We hypothesize that this combinatorial approach may enhance antitumor efficacy by coupling TMZ-induced DNA damage with AZD-mediated inhibition of ATM-dependent DNA repair, thereby sensitizing GBM cells to treatment.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Universidade Federal Fluminense
  • 2 Institut Català de Nanociència i Nanotecnologia
Track
  • TL03 - Biological and Medicinal Inorganic Chemistry
Keywords
Graphene oxide
Glioblastoma
Drug delivery